How does Metformin impact systemic inflammation in patients with metabolic syndrome or obesity? Does it reduce levels of pro-inflammatory cytokines?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Metformin impact systemic inflammation in patients with metabolic syndrome or obesity? Does it reduce levels of pro-inflammatory cytokines?
Metformin moderates systemic inflammation in patients with metabolic syndrome or obesity by reducing levels of pro-inflammatory cytokines, such as TNF-α and IL-6.
Metformin is known to decrease systemic inflammation in obese patients by lowering pro-inflammatory cytokines, thus helping manage insulin resistance and other metabolic issues.
In obese or metabolically challenged individuals, Metformin effectively reduces systemic inflammation by suppressing the secretion of cytokines like TNF-alpha and interleukin-6.